| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.2 | 0.1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |